DBVTF — DBV Technologies S.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1613780 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -47,900,000 | -47,600,000 | 266,400,000 | 229,200,000 | 58,500,000 |
| Dec 2025 | 0 | — | -45,048,000 | -44,829,000 | 233,718,000 | 194,167,000 | 64,948,000 |
| Sep 2025 | 0 | — | -34,277,000 | -33,164,000 | 110,495,000 | 69,837,000 | 57,641,000 |
| Jun 2025 | 0 | — | -41,110,000 | -41,875,000 | 143,429,000 | 103,207,000 | 57,205,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-150,483,000
Investing CF
$-1,169,000
Financing CF
$365,082,000
CapEx
$-928,000
Dividends Paid
—
Buybacks
$-152,000
EPS Diluted TTM
$-1.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-440,700,000
Inventory
—
Receivables
$15,100,000
ST Investments
—
EBIT TTM
$-168,335,000
Pretax Income TTM
$-166,777,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,736,000
EBITDA
$-165,162,000
Free Cash Flow
$-87,206,000
Enterprise Value
$1,037,495,232
Total Cash
$229,200,000
Total Debt
$6,100,000
Shares Out
295,932,279
Trailing EPS
$-0.90
Book Value
$0.70
ROE
-158.9%
ROA
-66.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -147,054,000 | -146,947,000 | 233,718,000 | 64,948,000 | — | -121,181,000 |
| Dec 2024 | 0 | -116,590,000 | -113,918,000 | 65,658,000 | 38,271,000 | — | -104,474,000 |
| Dec 2023 | 0 | -76,433,000 | -72,726,000 | 182,986,000 | 42,799,000 | — | -79,653,000 |
| Dec 2022 | 0 | -96,631,000 | -96,274,000 | 246,518,000 | 52,065,000 | — | -55,666,000 |
TTM Snapshot
Revenues TTM
$3,533,000
NetIncome TTM
$-49,852,000
OpCashFlow TTM
$0
Assets (Latest)
$65,658,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $181.31B | $335.94 | — |
| GILD | GILEAD SCIENCES, INC. | $166.04B | $133.73 | — |
| ARGX | ARGENX SE | $50.27B | $808.43 | — |
| RVMD | Revolution Medicines, Inc. | $32.93B | $154.89 | — |
| BIIB | BIOGEN INC. | $28.51B | $193.08 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
2026-05-21 15:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
2026-05-18 15:11 · Yahoo
Combined General Meeting of June 3, 2026
2026-05-13 20:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading
2026-05-13 15:12 · Yahoo
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
2026-05-12 20:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading
2026-05-12 15:14 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
2026-05-11 15:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Friday
2026-05-08 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
2026-05-01 15:10 · Yahoo
DBV Technologies Reports First Quarter 2026 Financial Results
2026-04-30 20:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.